Barclays’s iShares US Medical Devices ETF IHI Stock Holding History

Barclays’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-60,600	Closed	-$2.3M	–	7108
2018 Q3	$2.3M	Buy	+60,600	New	+$2.15M	﹤0.01%	2725
2018 Q2	–	Sell	-20,400	Closed	-$629K	–	7093
2018 Q1	$629K	Buy	+20,400	New	+$628K	﹤0.01%	3727
2017 Q3	–	Sell	-8,400	Closed	-$233K	–	6928
2017 Q2	$233K	Hold	8,400	–	–	﹤0.01%	4243
2017 Q1	$212K	Buy	+8,400	New	+$204K	﹤0.01%	4254

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays's IHI Position: Q1 2026 in Review

Barclays increased its iShares US Medical Devices ETF (IHI) stake by 8,749% in Q1 2026, buying an estimated $5.92M and bringing the position to 101,945 shares worth $5.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

Barclays first reported a position in IHI in Q2 2013 and has held it in 34 quarters since. The position peaked at $61.9M in Q2 2021. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Barclays held 101,945 shares of iShares US Medical Devices ETF worth $5.44M as of Q1 2026.
Barclays bought 100,793 iShares US Medical Devices ETF shares in Q1 2026, an estimated $5.92M.
iShares US Medical Devices ETF made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1764 holding.
Barclays first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 34 quarters since.
Barclays's iShares US Medical Devices ETF position peaked at $61.9M in Q2 2021.
504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.